How much did Cresco Labs achieve in EBIT for the current year?
In the current year, Cresco Labs has achieved an EBIT of 109.54 M USD.
Cresco Labs EBIT 2024
Cresco Labs EBIT
109.54 M USD
Ticker
CL.CN
ISIN
CA22587M1068
WKN
A2PAHM
In 2024, Cresco Labs's EBIT was 109.54 M USD, a 73.34% increase from the 63.19 M USD EBIT recorded in the previous year.
The Cresco Labs EBIT history
| YEAR | EBIT (undefined USD) |
|---|---|
| 2026e | 0.16 |
| 2025e | 27.8 |
| 2024e | 0.11 |
| 2023 | 0.06 |
| 2022 | 0.06 |
| 2021 | 0.09 |
| 2020 | -0.02 |
| 2019 | -0.05 |
| 2018 | -0.04 |
| 2017 | -0 |
| 2016 | -0 |
| 2014 | -0 |
Cresco Labs Revenue, EBIT, Net Income CA22587M1068 · A2PAHM
3 years
5 years
10 years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Cresco Labs, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Cresco Labs from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Cresco Labs’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Cresco Labs. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Cresco Labs’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Cresco Labs’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Cresco Labs’s growth potential.
Cresco Labs Revenue, EBIT and net profit per share
| Date | Cresco Labs Revenue | Cresco Labs EBIT | Cresco Labs Net Income |
|---|---|---|---|
| 2026e | 893.78 M undefined | 163.56 M undefined | 64.3 M undefined |
| 2025e | 816.94 M undefined | 27.8 B undefined | 4.25 M undefined |
| 2024e | 767.7 M undefined | 109.54 M undefined | -16.53 M undefined |
| 2023 | 770.89 M undefined | 63.19 M undefined | -175.52 M undefined |
| 2022 | 842.68 M undefined | 56.36 M undefined | -212.05 M undefined |
| 2021 | 821.68 M undefined | 88.54 M undefined | -319.6 M undefined |
| 2020 | 476.25 M undefined | -22.25 M undefined | -102.16 M undefined |
| 2019 | 128.53 M undefined | -52.71 M undefined | -43.2 M undefined |
| 2018 | 43.25 M undefined | -44.13 M undefined | -1.92 M undefined |
| 2017 | 0 undefined | -41,275 undefined | -79,310 undefined |
| 2016 | 0 undefined | -42,299 undefined | -106,628 undefined |
| 2014 | 0 undefined | -46,397 undefined | -74,317 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2014 | 0 USD | -46,397 USD | -74,317 USD |
| 2016 | 0 USD | -42,299 USD | -106,628 USD |
| 2017 | 0 USD | -41,275 USD | -79,310 USD |
| 2018 | 43.25 M USD | -44.13 M USD | -1.92 M USD |
| 2019 | 128.53 M USD | -52.71 M USD | -43.2 M USD |
| 2020 | 476.25 M USD | -22.25 M USD | -102.16 M USD |
| 2021 | 821.68 M USD | 88.54 M USD | -319.6 M USD |
| 2022 | 842.68 M USD | 56.36 M USD | -212.05 M USD |
| 2023 | 770.89 M USD | 63.19 M USD | -175.52 M USD |
| 2024e | 767.7 M USD | 109.54 M USD | -16.53 M USD |
| 2025e | 816.94 M USD | 27.8 B USD | 4.25 M USD |
| 2026e | 893.78 M USD | 163.56 M USD | 64.3 M USD |
Cresco Labs stock margins CA22587M1068 · A2PAHM
The Cresco Labs margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cresco Labs. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cresco Labs.
3 years
5 years
10 years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Cresco Labs's sales revenue. A higher gross margin percentage indicates that the Cresco Labs retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Cresco Labs's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Cresco Labs's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Cresco Labs's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Cresco Labs. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Cresco Labs's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Cresco Labs Margin History
| Cresco Labs Gross margin | Cresco Labs Profit margin | Cresco Labs EBIT margin | Cresco Labs Profit margin |
|---|---|---|---|
| 2026e | 47.01 % | 18.3 % | 7.19 % |
| 2025e | 47.01 % | 3,402.33 % | 0.52 % |
| 2024e | 47.01 % | 14.27 % | -2.15 % |
| 2023 | 47.01 % | 8.2 % | -22.77 % |
| 2022 | 48.3 % | 6.69 % | -25.16 % |
| 2021 | 49.45 % | 10.78 % | -38.9 % |
| 2020 | 43.4 % | -4.67 % | -21.45 % |
| 2019 | 35.5 % | -41.01 % | -33.61 % |
| 2018 | -28.08 % | -102.02 % | -4.43 % |
| 2017 | 47.01 % | 0 % | 0 % |
| 2016 | 47.01 % | 0 % | 0 % |
| 2014 | 47.01 % | 0 % | 0 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2014 | 47.01 % | 0 % | 0 % |
| 2016 | 47.01 % | 0 % | 0 % |
| 2017 | 47.01 % | 0 % | 0 % |
| 2018 | -28.08 % | -102.02 % | -4.43 % |
| 2019 | 35.5 % | -41.01 % | -33.61 % |
| 2020 | 43.4 % | -4.67 % | -21.45 % |
| 2021 | 49.45 % | 10.78 % | -38.9 % |
| 2022 | 48.3 % | 6.69 % | -25.16 % |
| 2023 | 47.01 % | 8.2 % | -22.77 % |
| 2024e | 47.01 % | 14.27 % | -2.15 % |
| 2025e | 47.01 % | 3,402.33 % | 0.52 % |
| 2026e | 47.01 % | 18.3 % | 7.19 % |
Cresco Labs Aktienanalyse
What does Cresco Labs do?
Cresco Labs Inc is an American cannabis and hemp company based in Chicago, Illinois. The company specializes in producing high-quality cannabis products and has a reputation for being innovative and reliable. Its diverse business model includes producing medical cannabis and recreational marijuana in various forms, as well as providing services such as consulting, training, marketing, and sales promotion. Cresco Labs has experienced impressive growth since its founding in 2013 and aims to expand its reach and product offerings. The company is committed to sustainability, social responsibility, and promoting education and access to medical cannabis. Cresco Labs ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Cresco Labs's EBIT
Cresco Labs's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Cresco Labs's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Cresco Labs's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Cresco Labs’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Cresco Labs Stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Cresco Labs.
How has the EBIT of Cresco Labs developed in recent years?
The EBIT of Cresco Labs has increased by 73.339% increased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Cresco Labs?
The EBIT of Cresco Labs is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Cresco Labs pay?
Over the past 12 months, Cresco Labs paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cresco Labs is expected to pay a dividend of 0 USD.
What is the dividend yield of Cresco Labs?
The current dividend yield of Cresco Labs is .
When does Cresco Labs pay dividends?
Cresco Labs pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Cresco Labs?
Cresco Labs paid dividends every year for the past 0 years.
What is the dividend of Cresco Labs?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Cresco Labs located?
Cresco Labs is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cresco Labs kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cresco Labs from 7/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/2/2024.
When did Cresco Labs pay the last dividend?
The last dividend was paid out on 7/2/2024.
What was the dividend of Cresco Labs in the year 2023?
In the year 2023, Cresco Labs distributed 0 USD as dividends.
In which currency does Cresco Labs pay out the dividend?
The dividends of Cresco Labs are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Cresco Labs stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Cresco Labs
Our stock analysis for Cresco Labs Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cresco Labs Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
